About Kishiwada City Hospital
市立岸和田市民病院は、大阪府岸和田市にある医療機関である。岸和田市病院事業の設置等に関する条例により設置された市立の病院である。臨床研修認定病院や国指定がん診療拠点病院などの指定を受けている。 公益財団法人日本医療機能評価機構認定病院。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kishiwada City Hospital
During the past decade, Kishiwada City Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
2005-07-01
2014-05-01
Completed
709
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
2004-06-01
2006-11-01
Completed
360
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
2006-10-01
2011-04-01
Completed
142
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
2007-09-01
2012-07-01
Completed
55
Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura
2008-02-01
2013-12-01
Completed
18
Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study
2009-05-01
2011-08-01
Completed
178
Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors
2010-01-01
2012-10-01
Completed
78
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
2010-03-01
2012-06-01
Completed
525
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kishiwada City Hospital"
#1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kishiwada City Hospital
According to Clinical.Site data, the most researched conditions in "Kishiwada City Hospital" are
"Pulmonary Disease, Chronic Obstructive" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Non-small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Kishiwada City Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kishiwada City Hospital
Most popular intervention types in "Kishiwada City Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (1 trials), "Carboplatin" (1 trials), "Pemetrexed" (1 trials), "olodaterol" (1 trials) and "tiotropium" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kishiwada City Hospital
The vast majority of trials in "Kishiwada City Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Kishiwada City Hospital
Currently, there are NaN active trials in "Kishiwada City Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kishiwada City Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kishiwada City Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".